TheraBiogen Announced Deal with Miami Heat and Walgreens Back in February

Oxford, MS 3/31/2011 (Penny PayDay) – Back in February, TheraBiogen, Inc. (OTC:TRAB) announced, in a press release, that it has entered into a partnership with the Miami HEAT and South Florida Walgreens. Shares of TheraBiogen closed yesterday at $0.99 per share and average just over 9,000 shares traded per day. The company has a market cap of $38 million and a 52-week range between $0.40 and $1.80 per share.

According to the press release, through a relationship with JumpStart, Inc., TheraMax was chosen as an official partner of a program between the Miami HEAT and Walgreens. The program will encompass product sales and promotions in Walgreens pharmacies in South Florida as well as joint promotion on select Miami HEAT advertising and marketing assets.

According to the press release, TheraBiogen has been selling TheraMax Cold & Flu Relief and TheraMax Allergy Relief since the beginning of the 2010 Fall Season for cold and flu relief. TheraMax products are homeopathic nasal sprays that do not contain zinc.

“We are very excited to team up with the HEAT and Walgreens on this opportunity,” said Kelly Hickel, CEO of TheraBiogen, Inc. “This will make more consumers aware of our products and provide an important product to Walgreens customers. As we expand our presence in South Florida Walgreens, we expect to see the same great support from consumers that we have seen since our national launch in October of last year.”

TheraBiogen is the manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies and cold and flu symptoms. The products are made from natural, homeopathic ingredients and contain no zinc.

For further information please visit www.theramaxrelief.com.

Distributed by IntelBuilder Social Media Platform